Abstract
Diabetic complications may result from chronic glycosylation of protein within cells and in the extracellular matrix. Prevention of glycosylation with aminoguanidine has forestalled complications in experimental diabetes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 46-50 |
| Number of pages | 5 |
| Journal | Hospital Practice |
| Volume | 27 |
| Issue number | SUPPL. 1 |
| State | Published - 1992 |
ASJC Scopus subject areas
- General Medicine
